Pharmaceutical nanotechnology · 2025
Cracking the Code: How Nano-Informatics is Crafting Intelligent Nano-Weapons to Outsmart Multiple Drug Resistance (MDR).
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sinoliya Priyanka, Niraj Ravi Ranjan Kumar, Sharma Vinay
Аннотация
INTRODUCTION: Multiple Drug Resistance (MDR) is one of the prime concerns globally in the health sector. The emergence and proliferation of ESKAPE pathogens, along with drug resistance in cancer cells, represent a significant challenge to public health, emphasizing the need for novel therapeutics, improved infection control practices, and ongoing research to understand and combat antibiotic resistance. Addressing multiple drug resistance involves several modern therapeutic strategies, such as phage therapy, immunotherapy, combinatorial therapy, and more. Advanced diagnostic tools, effective control measures, and stringent regulatory and policy initiatives raising public awareness are also crucial.
METHODS: This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.
RESULTS: This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.
DISCUSSION: This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.
CONCLUSION: To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.
METHODS: This study scouted computational approaches, focusing on their application in nanotechnology and nano-drug systems in clinical settings. A systematic approach was employed to gather, screen, and critically analyze the relevant literature for this review.
RESULTS: This study found that various tools and databases are evolving for reconnaissance in the field of nano-informatics, which will lead to research and development.
DISCUSSION: This study highlights the rapid advancement of nano-informatics tools and databases, which are crucial for advancing computational approaches in nanomedicine and therapeutic research. These emerging resources support predictive analysis and integration with biological datasets, though challenges remain in data standardization, accessibility, and interoperability across platforms.
CONCLUSION: To mitigate multiple drug resistance, researchers are exploring various approaches, and nano-informatics can provide new insight into dealing with it. This approach will advance the development of medical devices, drug design, and delivery systems.